| Patent | Date |
|---|
Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof
App 20220073500 - BURNIER; John ; et al. | 2022-03-10 |
Compositions And Methods For Treatment Of Diabetic Retinopathy
App 20210338839 - BURNIER; John ; et al. | 2021-11-04 |
Crystalline pharmaceutical and methods of preparation and use thereof
Grant 11,028,077 - Burnier , et al. June 8, 2 | 2021-06-08 |
Compositions and methods for treatment of diabetic retinopathy
Grant 10,960,087 - Burnier , et al. March 30, 2 | 2021-03-30 |
Compositions and methods for treatment
Grant 10,188,641 - Gadek , et al. Ja | 2019-01-29 |
Methods And Compositions For Treating Inflammatory Disorders
App 20170312334 - Gadek; Thomas | 2017-11-02 |
Compositions And Methods For Treatment
App 20170143690 - GADEK; Thomas ; et al. | 2017-05-25 |
Compositions And Methods For Treatment
App 20170143692 - GADEK; Thomas ; et al. | 2017-05-25 |
Compositions And Methods For Treatment
App 20170143693 - GADEK; Thomas ; et al. | 2017-05-25 |
Compositions And Methods For Treatment
App 20170143691 - GADEK; Thomas ; et al. | 2017-05-25 |
Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof
App 20160368902 - BURNIER; John ; et al. | 2016-12-22 |
Crystalline pharmaceutical and methods of preparation and use thereof
Grant 9,447,077 - Burnier , et al. September 20, 2 | 2016-09-20 |
Compositions And Methods For Treatment Of Diabetic Retinopathy
App 20160220702 - BURNIER; John ; et al. | 2016-08-04 |
Topical Formulations Of Chemerin C15 Peptides For The Treatment Of Dermatological Conditions
App 20160136231 - GADEK; Thomas | 2016-05-19 |
Compositions And Methods For Treatment
App 20150216857 - Gadek; Thomas ; et al. | 2015-08-06 |
Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof
App 20150218135 - BURNIER; John ; et al. | 2015-08-06 |
Compositions And Methods For Treatment
App 20150182520 - Gadek; Thomas ; et al. | 2015-07-02 |
Compositions And Methods For Treatment
App 20150175579 - Gadek; Thomas ; et al. | 2015-06-25 |
Compositions And Methods For Treatment
App 20150175577 - Gadek; Thomas ; et al. | 2015-06-25 |
Compositions And Methods For Treatment
App 20150175580 - Gadek; Thomas ; et al. | 2015-06-25 |
Compositions And Methods For Treatment
App 20150175578 - Gadek; Thomas ; et al. | 2015-06-25 |
Compositions And Methods For Treatment
App 20150175581 - Gadek; Thomas ; et al. | 2015-06-25 |
Compositions And Methods For Treatment
App 20150174119 - Gadek; Thomas ; et al. | 2015-06-25 |
Compositions And Methods For Treatment
App 20150152090 - Gadek; Thomas ; et al. | 2015-06-04 |
Compositions and methods for treatment
Grant 9,045,457 - Gadek , et al. June 2, 2 | 2015-06-02 |
Compositions And Methods For Treatment
App 20150140078 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20150140076 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20150140081 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20150140080 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20150140075 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20150140079 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20150140077 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20150140082 - Gadek; Thomas ; et al. | 2015-05-21 |
Compositions And Methods For Treatment
App 20140378506 - Gadek; Thomas ; et al. | 2014-12-25 |
Compositions And Methods For Treatment
App 20140371265 - Gadek; Thomas ; et al. | 2014-12-18 |
Topical Formulations Of Chemerin C15 Peptides For The Treatment Of Dermatological Conditions
App 20140349943 - Gadek; Thomas | 2014-11-27 |
Crystalline pharmaceutical and methods of preparation and use thereof
Grant 8,871,935 - Burnier , et al. October 28, 2 | 2014-10-28 |
Compositions And Methods For Treatment
App 20140161872 - Gadek; Thomas ; et al. | 2014-06-12 |
Compositions And Methods For Treatment
App 20140141062 - Gadek; Thomas ; et al. | 2014-05-22 |
Compositions And Methods For Treatment
App 20140099387 - Gadek; Thomas ; et al. | 2014-04-10 |
Aerosolized Lfa-1 Antagonists For Use In Localized Treatment Of Immune Related Disorders
App 20140079784 - Burnier; John ; et al. | 2014-03-20 |
Compositions And Methods For Treatment
App 20140073666 - Gadek; Thomas ; et al. | 2014-03-13 |
Topical Lfa-1 Antagonists For Use In Localized Treatment Of Immune Related Disorders
App 20140051722 - Burnier; John ; et al. | 2014-02-20 |
Compositions and methods for treatment of eye disorders
Grant 8,592,450 - Gadek , et al. November 26, 2 | 2013-11-26 |
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
App 20130144063 - BURNIER; John ; et al. | 2013-06-06 |
Crystalline pharmaceutical and methods of preparation and use thereof
Grant 8,367,701 - Burnier , et al. February 5, 2 | 2013-02-05 |
Compositions and Methods for Treatment of Eye Disorders
App 20120232019 - Gadek; Thomas ; et al. | 2012-09-13 |
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
App 20120107404 - Burnier; John ; et al. | 2012-05-03 |
Compositions and methods for treatment of eye disorders
Grant 8,168,655 - Gadek , et al. May 1, 2 | 2012-05-01 |
Crystalline pharmaceutical and methods of preparation and use thereof
Grant 8,080,562 - Burnier , et al. December 20, 2 | 2011-12-20 |
Compositions and Methods for Treatment
App 20110165228 - BURNIER; John ; et al. | 2011-07-07 |
Compositions and Methods for Treatment
App 20110165229 - BURNIER; John ; et al. | 2011-07-07 |
Compositions And Methods For Treatment Of Eye Disorders
App 20100092541 - Burnier; John ; et al. | 2010-04-15 |
Compositions And Methods For Treatment Of Eye Disorders
App 20100092542 - Burnier; John ; et al. | 2010-04-15 |
Crystalline pharmaceutical and methods of preparation and use thereof
App 20090298869 - Burnier; John ; et al. | 2009-12-03 |
Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
App 20090257957 - Burnier; John ; et al. | 2009-10-15 |
Topical LFA-1 antagonists for use in localized treatment of immune related disorders
App 20090258070 - Burnier; John ; et al. | 2009-10-15 |
Delivery of LFA-1 antagonists to the gastrointestinal system
App 20090258069 - Burnier; John ; et al. | 2009-10-15 |
Compositions and methods for treatment of diabetic retinopathy
App 20090155176 - Burnier; John ; et al. | 2009-06-18 |
Compositions and methods for treatment of eye disorders
App 20060281739 - Gadek; Thomas ; et al. | 2006-12-14 |
(2S)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrhydropyrim idin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
Grant 6,867,213 - Peyman , et al. March 15, 2 | 2005-03-15 |
Thienylalanine derivatives as inhibitors of cell adhesion
Grant 6,762,190 - Gadek , et al. July 13, 2 | 2004-07-13 |
(2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyr- imidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
App 20040039006 - Peyman, Aunschirwan ; et al. | 2004-02-26 |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
Grant 6,660,728 - Scheunemann , et al. December 9, 2 | 2003-12-09 |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
App 20030153557 - Scheunemann, Karl-Heinz ; et al. | 2003-08-14 |
Thienylalanine derivatives as inhibitors of cell adhesion
App 20030105080 - Gadek, Thomas ; et al. | 2003-06-05 |
Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor
Grant 5,565,449 - Blackburn , et al. October 15, 1 | 1996-10-15 |
Platelet aggregation inhibitors having high specificity for GPIIBIIIA
Grant 5,493,007 - Burnier , et al. February 20, 1 | 1996-02-20 |
| 